PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34461908-0	2021	The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer.	avasimibe	41-50	E2F transcription factor 1 L homeolog	Xenopus laevis	106-111	
34461908-12	2021	Moreover, E2F-1 was elevated after treatment with avasimibe.	avasimibe	50-59	E2F transcription factor 1 L homeolog	Xenopus laevis	10-15	
34461908-13	2021	After knockdown of E2F-1 expression, the inhibition of cell proliferation and migration caused by avasimibe was significantly recovered.	avasimibe	98-107	E2F transcription factor 1 L homeolog	Xenopus laevis	19-24	
34461908-15	2021	Immunofluorescence staining revealed lower levels of Ki67 and higher levels of E2F-1 in tumour tissues of the avasimibe group than those of the control group.	avasimibe	110-119	E2F transcription factor 1 L homeolog	Xenopus laevis	79-84	
34461908-18	2021	CONCLUSIONS: Our results suggest that avasimibe can suppress tumour proliferation and metastasis via the E2F-1 signalling pathway.	avasimibe	38-47	E2F transcription factor 1 L homeolog	Xenopus laevis	105-110